Chugai Pharmaceutical Co. Ltd. - Free Cash Flow To Equity

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Free-Cash-Flow-To-Equity" stands at -248.97 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 06/30/2012, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of -349.29 Billion JPY for the item "Free Cash Flow To Equity" represents a decrease of -478.40 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of -349.29 Billion JPY for the item "Free Cash Flow To Equity" represents a decrease of -1,146.85 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of -248.97 Billion JPY for the item "Free Cash Flow To Equity" represents a decrease of -444.30 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -334.24 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -334.24 Billion Japanese Yens.
The 3 year change is -541.10 Billion Japanese Yens.
The 5 year change is -367.72 Billion Japanese Yens.
The 10 year change is -242.03 Billion Japanese Yens.

The Serie's long term average value is 52.51 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -301.47 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -584.96 Billion.